This company is no longer active
DNAC Stock Overview
Social Capital Suvretta Holdings Corp. III does not have significant operations.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Social Capital Suvretta Holdings Corp. III Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$8.63 |
| 52 Week High | US$10.55 |
| 52 Week Low | US$8.03 |
| Beta | 0 |
| 1 Month Change | -12.65% |
| 3 Month Change | -12.87% |
| 1 Year Change | -13.53% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -14.64% |
Recent News & Updates
Recent updates
Shareholder Returns
| DNAC | US Capital Markets | US Market | |
|---|---|---|---|
| 7D | 2.6% | 2.6% | 1.2% |
| 1Y | -13.5% | 31.6% | 24.9% |
Return vs Industry: DNAC exceeded the US Capital Markets industry which returned -21.1% over the past year.
Return vs Market: DNAC exceeded the US Market which returned -18.7% over the past year.
Price Volatility
| DNAC volatility | |
|---|---|
| DNAC Average Weekly Movement | 6.4% |
| Capital Markets Industry Average Movement | 3.5% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: DNAC has not had significant price volatility in the past 3 months.
Volatility Over Time: DNAC's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2021 | n/a | Chamath Palihapitiya | n/a |
Social Capital Suvretta Holdings Corp. III does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus on searching for a target business operating in the biotechnology industry and within the organ space sub-sector.
Social Capital Suvretta Holdings Corp. III Fundamentals Summary
| DNAC fundamental statistics | |
|---|---|
| Market cap | US$275.21m |
| Earnings (TTM) | -US$6.77m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-40.7x
P/E RatioIs DNAC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DNAC income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$6.77m |
| Earnings | -US$6.77m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.21 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -0.4% |
How did DNAC perform over the long term?
See historical performance and comparison